Becton, Dickinson and Company $BDX Shares Sold by Cary Street Partners Financial LLC

Cary Street Partners Financial LLC reduced its position in shares of Becton, Dickinson and Company (NYSE:BDX - Free Report) by 58.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,930 shares of the medical instruments supplier's stock after selling 5,556 shares during the period. Cary Street Partners Financial LLC's holdings in Becton, Dickinson and Company were worth $677,000 at the end of the most recent quarter.Intuitive Surgical Gives Buying Opportunity Off Its 52 Week HighsOther institutional investors and hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. raised its holdings in shares of Becton, Dickinson and Company by 15.4% in the 2nd quarter. Vanguard Group Inc. now owns 32,308,749 shares of the medical instruments supplier's stock worth $5,565,182,000 after purchasing an additional 4,305,947 shares in the last quarter. Norges Bank acquired a new position in Becton, Dickinson and Company in the second quarter worth approximately $653,377,000. First Eagle Investment Management LLC increased its holdings in shares of Becton, Dickinson and Company by 59.2% in the second quarter. First Eagle Investment Management LLC now owns 8,786,190 shares of the medical instruments supplier's stock valued at $1,513,421,000 after buying an additional 3,268,478 shares in the last quarter. GQG Partners LLC acquired a new stake in shares of Becton, Dickinson and Company during the 1st quarter valued at $689,833,000. Finally, Massachusetts Financial Services Co. MA boosted its stake in shares of Becton, Dickinson and Company by 24.4% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 8,514,446 shares of the medical instruments supplier's stock worth $1,466,613,000 after acquiring an additional 1,670,590 shares in the last quarter. 86.97% of the stock is owned by institutional investors and hedge funds. Insiders Place Their BetsIn other Becton, Dickinson and Company news, Director Bertram L. Scott sold 217 shares of the company's stock in a transaction dated Friday, November 7th. The stock was sold at an average price of $176.58, for a total value of $38,317.86. Following the transaction, the director directly owned 35,816 shares of the company's stock, valued at $6,324,389.28. This represents a 0.60% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Over the last quarter, insiders sold 407 shares of company stock valued at $73,922. Corporate insiders own 0.36% of the company's stock. Analyst Upgrades and DowngradesHealthcare Stocks With at Least 30 Years of Dividend IncreasesA number of equities research analysts have recently issued reports on the company. Argus boosted their target price on Becton, Dickinson and Company from $220.00 to $230.00 in a research report on Monday, September 15th. Piper Sandler dropped their price target on Becton, Dickinson and Company from $200.00 to $190.00 and set a "neutral" rating on the stock in a research note on Friday, November 7th. Morgan Stanley upped their price objective on shares of Becton, Dickinson and Company from $197.00 to $210.00 and gave the company an "overweight" rating in a research note on Tuesday, December 2nd. Royal Bank Of Canada dropped their target price on shares of Becton, Dickinson and Company from $211.00 to $202.00 and set a "sector perform" rating on the stock in a research report on Friday, November 7th. Finally, Weiss Ratings restated a "hold (c-)" rating on shares of Becton, Dickinson and Company in a research report on Wednesday, October 8th. Four analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company's stock. Based on data from MarketBeat, Becton, Dickinson and Company has an average rating of "Hold" and an average price target of $204.91.Read Our Latest Stock Analysis on BDXBecton, Dickinson and Company Price PerformanceNYSE BDX opened at $198.44 on Thursday. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.11 and a quick ratio of 0.64. The firm has a market capitalization of $56.64 billion, a price-to-earnings ratio of 34.04, a price-to-earnings-growth ratio of 1.74 and a beta of 0.25. The company has a 50 day simple moving average of $188.58 and a 200-day simple moving average of $184.19. Becton, Dickinson and Company has a 52-week low of $162.29 and a 52-week high of $251.99. Becton, Dickinson and Company (NYSE:BDX - Get Free Report) last released its quarterly earnings data on Thursday, April 14th. The medical instruments supplier reported $4.10 earnings per share for the quarter. The firm had revenue of $5.32 billion for the quarter. Becton, Dickinson and Company had a net margin of 7.68% and a return on equity of 16.42%. Equities research analysts predict that Becton, Dickinson and Company will post 14.43 earnings per share for the current fiscal year. Becton, Dickinson and Company Increases DividendThe company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 31st. Investors of record on Monday, December 8th will be given a dividend of $1.05 per share. The ex-dividend date of this dividend is Monday, December 8th. This is a positive change from Becton, Dickinson and Company's previous quarterly dividend of $1.04. This represents a $4.20 dividend on an annualized basis and a yield of 2.1%. Becton, Dickinson and Company's payout ratio is 72.04%. Becton, Dickinson and Company Company Profile (Free Report)Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.Further ReadingFive stocks we like better than Becton, Dickinson and CompanyUsing the MarketBeat Dividend Tax CalculatorMarket Momentum: 3 Stocks Poised for Major BreakoutsAre Penny Stocks a Good Fit for Your Portfolio?3 Reasons Casey’s General Stores Will Continue Trending HigherThe Basics of Support and ResistanceGolden Cross Alert: 3 Stocks With Major Upside PotentialWant to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX - Free Report).This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Becton, Dickinson and Company Right Now?Before you consider Becton, Dickinson and Company, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Becton, Dickinson and Company wasn't on the list.While Becton, Dickinson and Company currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here